Cited by 80Developmental Biology and Gene RegulationGenomics and Chromatin DynamicsT-cell and B-cell Immunology

Notch3 and the Notch3‐upregulated RNA‐binding protein HuD regulate Ikaros alternative splicing

Open access
Bellavia, Diana, Mecarozzi, Marco, Campese, Antonio F, Grazioli, Paola, Talora, Claudio, Frati, Luigi, Gulino, Alberto, Screpanti, Isabella·2007·The EMBO Journal

Abstract

Constitutive activation of the transmembrane receptor, Notch3, and loss of function of the hematopoietic transcription repressor, Ikaros (IK), play direct roles in T-cell differentiation and leukemogenesis that are dependent on pre-T-cell receptor (pre-TCR) signaling. We demonstrate the occurrence of crosstalk between Notch3 and IK that results in transcriptional regulation of the gene encoding the pTalpha chain of the pre-TCR. We also show that, in the presence of the pre-TCR, constitutive activation of Notch3 in thymocytes causes increased expression of dominantnegative non-DNA-binding IK isoforms, which are able to restrain the IK inhibition of Notch3's transcriptional activation of pTalpha. This effect appears to be mediated by Notch3's pre-TCR-dependent upregulation of the RNA-binding protein, HuD. Notch3 signaling thus appears to play a critical role in the diminished IK activity described in several lymphoid leukemias. By exerting transcription-activating and transcription-repressing effects on the pTalpha promoter, Notch3 and IK cooperate in the fine-tuning of pre-TCR expression and function, which has important implications for the regulation of thymocyte differentiation and proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7601626

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HuD mediates alternative splicing of the Ikaros gene, possibly by suppressing exon 4 inclusion.

    “Furthermore, overexpression and down-regulation of HuD in T-cell lines demonstrated that it mediates alternative splicing of the Ikaros gene, possibly by suppressing exon 4 inclusion (Bellavia et al. 2007; Hinman and Lou 2008).”

    From Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction (2013) · cites this paper as Bellavia et al. 2007

    The section on HuD-dependent IK variants and Figure 6 report that HuD overexpression in T-cell lines increased short Ikaros dominant-negative isoforms, while HuD knockdown prevented Notch3-induced changes in those isoforms. The paper also identifies an exon-4-lacking Ikaros isoform, but does not establish that HuD specifically suppresses exon 4 inclusion; it leaves open effects on splicing and/or RNA stability. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bellavia, D., Mecarozzi, M., Campese, A. F., Grazioli, P., Talora, C., Frati, L., Gulino, A., & Screpanti, I.
Affiliations
  • Sapienza University of Rome (IT)
  • Istituto Neurologico Mediterraneo (IT)
  • Istituto Pasteur (IT)
Corresponding author
Screpanti, Isabella
Venue
The EMBO Journal
Published
2007-03-01
Volume
26
Issue
6
Pages
1670-1680
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2091129822
Cited by
80
References
1
Citations by year
2026: 1 · 2024: 3 · 2023: 3 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 2 · 2014: 8 · 2013: 7 · 2012: 6
FWCI
2.92
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
  • Ministero della Salute
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
Notch3, Ikaros, HUD, alternative splicing, pre-T cell receptor, thymocyte differentiation, T cell differentiation, lymphoid leukemia, transcriptional regulation, RNA-binding proteins, Notch3 signaling
MeSH terms
ELAV-Like Protein 4, Receptor, Notch3, Animals, Cell Differentiation, Flow Cytometry, Gene Expression Regulation, Luciferases, Membrane Glycoproteins, T-Lymphocytes, Blotting, Western, Signal Transduction, Receptors, Antigen, T-Cell, alpha-beta, Alternative Splicing, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, RNA Interference, Chromatin Immunoprecipitation, Cell Proliferation, Mice, Ikaros Transcription Factor, Receptors, Notch, ELAV Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review